Skip to main content
. 2016 May 25;11(5):e0156023. doi: 10.1371/journal.pone.0156023

Fig 1. HIV antibody kinetics (up) and box-and-whisker plots showing median of AI measurements at 50 days intervals (bottom) of the all 150 seroconverting individuals of the PHI cohort of Québec (A), the 123 treatment-naive patients of the PHI cohort of Québec (B), the individuals of the PHI cohort of Québec treated between 0 and 400 days post-seroconversion (C), using the CDC-modified Bio-Rad-Avidity assay.

Fig 1

The ‘recent/long-standing’ infection cutoff value is shown by the horizontal dashed line. AI: avidity index.